Article
Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.
Molecular & cellular proteomics : MCP - 1 Jul 2012
Warmoes Marc, Jaspers Janneke E, Pham Thang V, Piersma Sander R, Oudgenoeg Gideon, Massink Maarten P G, Waisfisz Quinten, Rottenberg Sven, Boven Epie, Jonkers Jos, Jimenez Connie R
Abstract excerpt
Breast cancer 1, early onset (BRCA1) hereditary breast cancer, a type of cancer with defects in the homology-directed DNA repair pathway, would benefit from the identification of proteins for diagnosis, which might also be of potential use as screening, prognostic, or predictive markers. Sporadic breast cancers with defects in the BRCA1 pathway might also be diagnosed. We employed proteomics based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
